Assistant Professor, Department of Population Health
I am an ethicist, a public health professional, and a medical historian. My research is primarily focused on ethics and policy issues concerning access to investigational medical products, both inside and outside of clinical trials. One particular area of interest is in the equity of access: who gets access to what, how?
In recent years, my colleagues and I have become interested in several areas of active inquiry: 1) can useful efficacy data be obtained from non-trial uses of unapproved medical products; 2) how to most ethically and pragmatically advance the new field of individualized therapeutics; 3) the ethics of pediatric gene therapy trials; and 4) what amount of and quality of data is needed to make clinical & regulatory decisions.
I am also interested in and conducted research on the history, ethics, & public policy of mandatory helmet laws.
PhD from Columbia University
MPH from Columbia University
NYU Grossman School of Medicine, Division of Medical Ethics
Annals of internal medicine. 2015 Nov 17; 163(10):796-7
Expert opinion on pharmacotherapy. 2015 Jun; 16(9):1275-9
Pharmaceutical medicine. 2022 Dec 17;
JAMA network open. 2022 Nov 01; 5(11):e2239766
Nucleic acid therapeutics. 2022 Apr; 32(2):111-117
American journal of bioethics : AJOB. 2022 Jan 01; 22(<prism:issueIdentifier>3):1-3
American journal of bioethics : AJOB. 2021 Oct 19; 1-16
Molecular therapy. 2021 Apr 07; 29(4):1367-1369